HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Li Xie Selected Research

Baizhu

3/2019Investigation on Spectrum-Effect Correlation between Constituents Absorbed into Blood and Bioactivities of Baizhu Shaoyao San before and after Processing on Ulcerative Colitis Rats by UHPLC/Q-TOF-MS/MS Coupled with Gray Correlation Analysis.
6/2018Discrimination of volatiles in herbal formula Baizhu Shaoyao San before and after processing using needle trap device with multivariate data analysis.
4/2018Profiling and analysis of multiple constituents in Baizhu Shaoyao San before and after processing by stir-frying using UHPLC/Q-TOF-MS/MS coupled with multivariate statistical analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Li Xie Research Topics

Disease

159Neoplasms (Cancer)
04/2024 - 08/2005
41Infections
04/2024 - 09/2005
34Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 05/2008
25Breast Neoplasms (Breast Cancer)
03/2024 - 02/2008
22Neoplasm Metastasis (Metastasis)
04/2024 - 08/2005
22Stomach Neoplasms (Stomach Cancer)
01/2024 - 06/2010
20Colorectal Neoplasms (Colorectal Cancer)
04/2024 - 04/2012
19Hepatocellular Carcinoma (Hepatoma)
01/2024 - 07/2004
16Lung Neoplasms (Lung Cancer)
10/2023 - 05/2008
16Inflammation (Inflammations)
10/2023 - 06/2016
16Rheumatoid Arthritis
03/2022 - 09/2013
13Carcinogenesis
11/2023 - 03/2010
13Pain (Aches)
01/2023 - 07/2013
11Nasopharyngeal Carcinoma
11/2022 - 09/2010
8COVID-19
04/2024 - 01/2021
8Fibrosis (Cirrhosis)
04/2024 - 01/2016
8Leukemia
01/2023 - 03/2014
7Wounds and Injuries (Trauma)
04/2024 - 10/2006
7Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2023 - 01/2013
6Diarrhea
02/2024 - 02/2014
6Alzheimer Disease (Alzheimer's Disease)
02/2023 - 01/2014
6Hemorrhage
01/2023 - 09/2015
6Type 2 Diabetes Mellitus (MODY)
01/2023 - 10/2007
6Carcinoma (Carcinomatosis)
01/2021 - 05/2008
5Necrosis
01/2024 - 08/2013
5Hypoxia (Hypoxemia)
11/2023 - 11/2012
5Lymphoma (Lymphomas)
08/2023 - 07/2012
5Disease Progression
02/2023 - 01/2016
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 06/2014
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2021 - 08/2015
5Chronic Hepatitis B
10/2019 - 01/2015
5Pancreatic Neoplasms (Pancreatic Cancer)
01/2018 - 05/2010
5Human Influenza (Influenza)
10/2015 - 12/2010
4Cardiovascular Diseases (Cardiovascular Disease)
04/2024 - 05/2009
4Hepatitis
03/2024 - 05/2006
4Adenocarcinoma of Lung
12/2023 - 06/2014
4Hypertension (High Blood Pressure)
11/2023 - 05/2009
4Chronic Disease (Chronic Diseases)
07/2023 - 10/2015
4Mitochondrial Diseases (Mitochondrial Disease)
04/2023 - 06/2019
4Osteosarcoma (Osteogenic Sarcoma)
01/2023 - 01/2018
4Adenocarcinoma
01/2023 - 06/2019
4Thyroid Nodule (Nodule, Thyroid)
10/2022 - 11/2020
4Glioma (Gliomas)
12/2021 - 03/2016
4Pancreatitis
10/2021 - 01/2017
4Rectal Neoplasms (Rectal Cancer)
05/2021 - 02/2014
4Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 09/2013

Drug/Important Bio-Agent (IBA)

71Biomarkers (Surrogate Marker)IBA
04/2024 - 07/2009
56Proteins (Proteins, Gene)FDA Link
04/2024 - 10/2006
25Messenger RNA (mRNA)IBA
04/2023 - 06/2010
23MicroRNAs (MicroRNA)IBA
01/2024 - 03/2010
15DNA (Deoxyribonucleic Acid)IBA
08/2023 - 08/2005
13CytokinesIBA
01/2024 - 04/2003
12baricitinibIBA
03/2022 - 03/2016
10EnzymesIBA
07/2023 - 10/2012
9Indicators and Reagents (Reagents)IBA
03/2024 - 01/2011
9Glucose (Dextrose)FDA LinkGeneric
01/2023 - 08/2011
8Therapeutic UsesIBA
04/2024 - 01/2013
8RNA (Ribonucleic Acid)IBA
01/2024 - 08/2005
8Reactive Oxygen Species (Oxygen Radicals)IBA
11/2023 - 01/2014
8Cisplatin (Platino)FDA LinkGeneric
10/2023 - 02/2009
8Long Noncoding RNAIBA
10/2023 - 11/2018
7tetraethylpyrazine (TEP)IBA
01/2024 - 09/2018
7AntigensIBA
11/2023 - 08/2005
7VaccinesIBA
11/2022 - 04/2003
7Peptides (Polypeptides)IBA
11/2022 - 01/2011
7Monoclonal AntibodiesIBA
01/2019 - 02/2012
6C-Reactive ProteinIBA
01/2024 - 09/2014
6Circular RNAIBA
01/2023 - 01/2021
5Interleukin-6 (Interleukin 6)IBA
03/2024 - 07/2014
5IonsIBA
12/2023 - 03/2021
5LigandsIBA
12/2022 - 01/2011
5Opioid Analgesics (Opioids)IBA
03/2022 - 09/2015
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2022 - 04/2003
5Phosphotransferases (Kinase)IBA
01/2022 - 04/2011
5Antirheumatic Agents (DMARD)IBA
06/2021 - 03/2016
5Docetaxel (Taxotere)FDA Link
12/2014 - 06/2010
4Cadherins (E-Cadherin)IBA
04/2024 - 11/2012
4B7-H1 AntigenIBA
01/2024 - 11/2016
4CalciumIBA
12/2023 - 09/2022
4Hemoglobins (Hemoglobin)IBA
10/2023 - 09/2016
4Arginine (L-Arginine)FDA Link
09/2023 - 01/2021
4Anti-Bacterial Agents (Antibiotics)IBA
09/2023 - 01/2021
4Tumor Biomarkers (Tumor Markers)IBA
07/2023 - 12/2010
4Transcription Factors (Transcription Factor)IBA
04/2023 - 01/2012
4Small Interfering RNA (siRNA)IBA
11/2022 - 08/2005
42-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA
10/2022 - 11/2020
4Silicon Dioxide (Silica)FDA LinkGeneric
08/2022 - 10/2019
4ErbB Receptors (EGF Receptor)IBA
01/2022 - 07/2014
4Insulin (Novolin)FDA Link
01/2020 - 05/2006
4AcidsIBA
06/2019 - 02/2010
4Temozolomide (Temodar)FDA LinkGeneric
06/2019 - 03/2016
4perillyl alcoholIBA
06/2019 - 03/2016

Therapy/Procedure

66Therapeutics
05/2024 - 05/2006
28Drug Therapy (Chemotherapy)
04/2024 - 05/2008
16Radiotherapy
01/2023 - 02/2008
12Immunotherapy
04/2024 - 07/2017
6Neoadjuvant Therapy
07/2021 - 10/2017
6Chemoradiotherapy
01/2021 - 01/2016
5Transplantation
02/2024 - 11/2016
4Lasers (Laser)
12/2022 - 01/2012